Figure 4

Receiver operating characteristic curve of Polη IHC counting in predicting chemotherapy response to FOLFOX or XELOX regimen.
Receiver operating characteristic curve of Polη IHC counting in predicting chemotherapy response to FOLFOX or XELOX regimen.